Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check5 days agoChange DetectedThe record history now lists a new Revision: v3.6.3, replacing Revision: v3.6.2, indicating an update to the page’s release version shown in the history.SummaryDifference0.1%

- Check12 days agoChange DetectedThe revision label on the record history page changed from v3.6.0 to v3.6.2, indicating a newer UI/system version for displaying history. This update does not alter the underlying study data, status, or results.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe record history now displays new fields 'Last verified' and 'Last known status was', and the revision label updated to v3.6.0 (replacing v3.5.5).SummaryDifference3%

- Check33 days agoChange DetectedA new Revision: v3.5.5 entry is added to the history, superseding the previous Revision: v3.5.4. This reflects a site-wide update to the page rendering or tooling rather than a change to the study data.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision labeled v3.5.4 has been added to the page's history, replacing the previous v3.5.3 entry and updating the version shown in the footer.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s footer now shows a new ClinicalTrials.gov site revision (v3.5.3 rather than v3.5.2), reflecting an update to the platform version rather than changes to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.